1. Home
  2. UTSI vs VNRX Comparison

UTSI vs VNRX Comparison

Compare UTSI & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UTStarcom Holdings Corp.

UTSI

UTStarcom Holdings Corp.

N/A

Current Price

$2.42

Market Cap

22.3M

ML Signal

N/A

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.76

Market Cap

24.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UTSI
VNRX
Founded
1991
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.3M
24.5M
IPO Year
1999
2012

Fundamental Metrics

Financial Performance
Metric
UTSI
VNRX
Price
$2.42
$0.76
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$1.67
AVG Volume (30 Days)
13.8K
421.3K
Earning Date
03-24-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.00
EPS
N/A
N/A
Revenue
N/A
$1,727,384.00
Revenue This Year
N/A
$355.66
Revenue Next Year
N/A
$849.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
40.04
52 Week Low
$2.00
$0.13
52 Week High
$3.63
$3.26

Technical Indicators

Market Signals
Indicator
UTSI
VNRX
Relative Strength Index (RSI) 46.53 29.74
Support Level $2.25 $0.69
Resistance Level $2.56 $1.55
Average True Range (ATR) 0.10 0.10
MACD 0.01 0.01
Stochastic Oscillator 42.50 12.31

Price Performance

Historical Comparison
UTSI
VNRX

About UTSI UTStarcom Holdings Corp.

UTStarcom Holdings Corp is engaged in providing telecommunication and networking products, solutions and services, focusing on optical networking, carrier-class packet optical, network synchronization, broadband products and a Software Defined Networking (SDN) platform optimized for AI networking infrastructure, mobile backhaul, metro aggregation, broadband access and value-added services. The Company operates through two segments: Equipment, which includes the sale of network infrastructure and application products such as broadband and wireless infrastructure technologies, and Services, which generates maximum revenue and provides support and operational services for equipment products. The Company generates maximum revenue from Japan.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.

Share on Social Networks: